Last updated: September 5, 2022
Sponsor: University of Nottingham
Overall Status: Active - Recruiting
Phase
N/A
Condition
Multiple Sclerosis
Neurologic Disorders
Scar Tissue
Treatment
N/AClinical Study ID
NCT05509426
21063
Ages 18-70 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- 18 or over and under 70 years of age.
- Have MS, diagnosed at least 3 months prior to recruitment.
- Have cognitive deficits, defined as performance below the 25th percentile on the BriefRepeatable Battery of Neuropsychological Tests (BRBN).
- Able to speak English sufficiently to complete the cognitive assessments and take partin group sessions.
- Have access to laptop or PC that supports MS Teams.
- Able to give informed consent.
Exclusion
Exclusion Criteria:
- Vision or hearing problems, such that they are unable to complete the cognitiveassessments, judged assessor.
- Have concurrent severe medical or psychiatric conditions which would preventparticipants from engaging in treatment, if allocated.
- Are involved in other psychological intervention trials.
Study Design
Total Participants: 36
Study Start date:
August 15, 2022
Estimated Completion Date:
November 30, 2023
Connect with a study center
Nottingham University Hospitals NHS Trust
Nottingham,
United KingdomActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.